The Now (The Now) Debt-to-Revenue : N/A (As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is The Now Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

The Now's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.23 Mil. The Now's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. The Now's annualized Revenue for the quarter that ended in Sep. 2015 was $0.00 Mil.

The Now Debt-to-Revenue Historical Data

The historical data trend for The Now's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Now Debt-to-Revenue Chart

The Now Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Debt-to-Revenue

Get a 7-Day Free Trial

0.47

0.97

0.61

The Now Quarterly Data
	Dec07	Dec08	Dec09	Dec10	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Sep14	Sep15
Debt-to-Revenue	Get a 7-Day Free Trial											0.62	0.78	0.80	N/A	N/A

Competitive Comparison of The Now's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, The Now's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Now's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Now's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where The Now's Debt-to-Revenue falls into.

The Now Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

The Now's Debt-to-Revenue for the fiscal year that ended in Dec. 2013 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(3.008	+	45.175)	/	78.846
	=	0.61

The Now's annualized Debt-to-Revenue for the quarter that ended in Sep. 2015 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.226	+	0)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Sep. 2015) Revenue data.

The Now Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of The Now's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

The Now (The Now) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Now Corp (OTCPK:NWPN) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3400 Pan American Drive, Unit 53, Miami, FL, USA, 33133

Website

https://www.thenowcorp.net

The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.

The Now (The Now) Headlines

From GuruFocus

The Now Corporation (OTC: NWPN) Ignites the African Gold Industry with a Game-Changing Acquisition

By ACCESSWIRE • 07-20-2023